Sartorius Stedim Biotech Stock
Stocks
DIM
FR0013154002
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 166.50 EUR | -5.02% |
|
-11.15% | -20.71% |
| Market Cap | 17.06B 19.47B 15.83B 14.55B 27.42B 1,878B 27.82B 189B 73.83B 919B 73.07B 71.5B 3,175B | P/E 2026 * |
44.6x | P/E 2027 * | 35x |
|---|---|---|---|---|---|
| Enterprise Value | 19.4B 22.14B 18.01B 16.55B 31.18B 2,136B 31.64B 215B 83.96B 1,045B 83.1B 81.31B 3,611B | EV / Sales 2026 * |
6.13x | EV / Sales 2027 * | 5.39x |
| Free-Float |
28.47% | Yield 2026 * |
0.49% | Yield 2027 * | 0.59% |
Last Transcript: Sartorius Stedim Biotech
| 1 day | -5.02% | ||
| 1 week | -11.15% | ||
| Current month | -8.31% | ||
| 1 month | +2.02% | ||
| 3 months | +5.45% | ||
| 6 months | -19.17% | ||
| Current year | -20.71% |
| 1 week | 158.9 |  | 189.2 |
| 1 month | 158.9 | | 190.8 |
| Current year | 150 | | 224 |
| 1 year | 150 | | 224 |
| 3 years | 139.1 | | 287.8 |
| 5 years | 139.1 | | 551 |
| 10 years | 50.13 | | 551 |
| Manager | Title | Age | Since |
|---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 51 | 2023-03-27 |
| Chief Tech/Sci/R&D Officer | 61 | 2011-09-07 | |
Petra Müller
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2015-04-06 | |
Susan Dexter
BRD | Director/Board Member | 69 | 2015-04-06 |
Lothar Kappich
BRD | Director/Board Member | 69 | 2017-09-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/17/25 | Sell | Company | 750,000 | 0.7706% | ||
| 2/16/24 | Buy | Chief Executive Officer | 1,716,739 | 1.8624% | ||
| 3/2/22 | Sell | Company | 200,442 | 0.2174% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.02% | -11.15% | -3.67% | -38.99% | 19.47B | |
| +0.90% | +12.66% | -20.01% | -12.00% | 175B | |
| -0.56% | +1.76% | -10.65% | -7.95% | 105B | |
| -0.82% | +1.35% | +2.60% | +56.07% | 58.48B | |
| -0.82% | -0.84% | +33.62% | +56.52% | 51.36B | |
| -0.44% | -1.11% | -15.51% | -42.17% | 42.2B | |
| -4.89% | -5.73% | - | - | 31.44B | |
| -4.44% | -1.79% | -16.08% | -45.31% | 27.56B | |
| -0.23% | -0.16% | +63.73% | -5.01% | 25.32B | |
| -0.56% | -0.42% | -5.87% | -9.27% | 20.52B | |
| Average | -1.54% | -0.18% | +3.13% | -5.35% | 55.64B | |
| Weighted average by Cap. | -0.66% | +3.58% | -4.61% | -1.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.17B 3.61B 2.94B 2.7B 5.09B 349B 5.16B 35B 13.7B 171B 13.56B 13.27B 589B | 3.5B 3.99B 3.24B 2.98B 5.62B 385B 5.7B 38.65B 15.13B 188B 14.97B 14.65B 651B |
| Net income | 380M 434M 353M 324M 611M 41.86B 620M 4.2B 1.65B 20.48B 1.63B 1.59B 70.76B | 475M 542M 441M 405M 763M 52.3B 775M 5.25B 2.06B 25.59B 2.03B 1.99B 88.41B |
| Net Debt | 2.34B 2.67B 2.17B 2B 3.76B 258B 3.82B 25.88B 10.13B 126B 10.03B 9.81B 436B | 1.77B 2.02B 1.64B 1.51B 2.84B 195B 2.88B 19.55B 7.65B 95.28B 7.58B 7.41B 329B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-23 | €166.50 | -5.02% | 73,781 |
| 26-07-22 | €175.30 | +5.22% | 134,439 |
| 26-07-21 | €166.60 | -7.55% | 213,161 |
| 26-07-20 | €180.20 | -2.96% | 55,079 |
| 26-07-17 | €185.70 | -0.91% | 107,069 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DIM Stock
Select your edition
All financial news and data tailored to specific country editions
